Competitor Analysis: Adenosine Receptor Agonists & Antagonists

The present Competitive Intelligence Report about Adenosine Receptor Agonists & Antagonists provides a competitor evaluation in the field of novel molecules being developed for treatment of a variety of diseases as of April 2011. Depending on the adenosine receptor subtype (A1, A2, A3) and on stimulation or blockade, molecules find use for treatment of diseases including glaucoma, dry eye, cardiac imaging, asthma, psoriasis, rheumatoid arthritis as well as Parkinson’s diasese. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. The report includes a compilation of currently active projects in research and development of novel adenosine receptor agonists & antagonists. In addition, the report lists company-specific R&D pipelines of adenosine receptor agonists & antagonists in R&D. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, Company, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information.

Additional Information

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.